Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corrigendum to 'Biosynthesis, characterisation and biocompatibility of a unique and elastomeric medium chain-length polyhydroxyalkanoate for kidney glomerular tissue engineering' [Mater. Today Bio 33 (2025), 101932].

Materials today. Bio·2026
Same author

Impact of Stiffness and Cell-Binding Motif Availability on the Cell-Specific Response to Collagen-Based Macromolecular Materials.

Biomacromolecules·2026
Same author

Complete Revascularisation in ST-elevation MI: Do We Really Buy It? Challenging the Current Approach to Bystander Percutaneous Coronary Intervention.

Interventional cardiology (London, England)·2026
Same author

Heat Shock Proteins as Cancer Biomarkers: From Mechanism to Clinical Application.

Molecular diagnosis & therapy·2026
Same author

Modulation of biomolecular condensation of alpha-synuclein variants by eprodisate.

Communications chemistry·2026
Same author

Therapeutic aptamers in drug discovery: future elements of the pharmaceutical arsenal?

Expert opinion on drug discovery·2026

Related Experiment Video

Updated: Nov 30, 2025

3D Human Myocardial Tissue Generation Using Melt Electrospinning Writing of Polycaprolactone Scaffolds and hiPSC-Derived Cardiac Cells
06:17

3D Human Myocardial Tissue Generation Using Melt Electrospinning Writing of Polycaprolactone Scaffolds and hiPSC-Derived Cardiac Cells

Published on: March 28, 2025

860

Natural Biomaterials for Cardiac Tissue Engineering: A Highly Biocompatible Solution.

Qasim A Majid1, Annabelle T R Fricker2, David A Gregory2

  • 1Faculty of Medicine, National Heart and Lung Institute, Imperial College London, London, United Kingdom.

Frontiers in Cardiovascular Medicine
|November 16, 2020
PubMed
Summary
This summary is machine-generated.

Cardiac Tissue Engineering (CTE) uses natural biomaterials like fibrinogen, collagen, alginate, and silk to regenerate heart tissue. These biocompatible materials show promise in improving cardiac function after myocardial infarction (MI).

Keywords:
alginatecardiac tissue engineeringcollagenengineered heart tissuefibrinogennatural biomaterialpolyhydroxyalkanoatesilk

More Related Videos

Processing of Human Cardiac Tissue Toward Extracellular Matrix Self-assembling Hydrogel for In Vitro and In Vivo Applications
08:41

Processing of Human Cardiac Tissue Toward Extracellular Matrix Self-assembling Hydrogel for In Vitro and In Vivo Applications

Published on: December 4, 2017

9.4K
Fabrication of Biologically Derived Injectable Materials for Myocardial Tissue Engineering
11:32

Fabrication of Biologically Derived Injectable Materials for Myocardial Tissue Engineering

Published on: December 20, 2010

15.4K

Related Experiment Videos

Last Updated: Nov 30, 2025

3D Human Myocardial Tissue Generation Using Melt Electrospinning Writing of Polycaprolactone Scaffolds and hiPSC-Derived Cardiac Cells
06:17

3D Human Myocardial Tissue Generation Using Melt Electrospinning Writing of Polycaprolactone Scaffolds and hiPSC-Derived Cardiac Cells

Published on: March 28, 2025

860
Processing of Human Cardiac Tissue Toward Extracellular Matrix Self-assembling Hydrogel for In Vitro and In Vivo Applications
08:41

Processing of Human Cardiac Tissue Toward Extracellular Matrix Self-assembling Hydrogel for In Vitro and In Vivo Applications

Published on: December 4, 2017

9.4K
Fabrication of Biologically Derived Injectable Materials for Myocardial Tissue Engineering
11:32

Fabrication of Biologically Derived Injectable Materials for Myocardial Tissue Engineering

Published on: December 20, 2010

15.4K

Area of Science:

  • Biomaterials Science
  • Regenerative Medicine
  • Cardiovascular Research

Background:

  • Cardiovascular diseases (CVD) are a leading global cause of mortality, accounting for 17.9 million deaths annually.
  • Current treatments for CVD often fall short, necessitating innovative approaches like Cardiac Tissue Engineering (CTE).
  • CTE aims to regenerate diseased cardiac tissue using a combination of biomaterials and cells.

Purpose of the Study:

  • To review the application of natural biomaterials in Cardiac Tissue Engineering (CTE).
  • To highlight the properties and efficacy of specific natural biomaterials for cardiac regeneration.
  • To assess the potential of CTE for future clinical applications in treating cardiovascular diseases.

Main Methods:

  • Focus on natural biomaterials for CTE, including fibrinogen, collagen, alginate, silk, and Polyhydroxyalkanoates (PHAs).
  • Review of pre-clinical studies utilizing various cell types (stem cells, iPSCs, ESCs) with these biomaterials.
  • Analysis of material properties supporting cell attachment, growth, differentiation, and functional tissue formation.

Main Results:

  • Natural biomaterials demonstrate high biocompatibility and sustainability.
  • Fibrinogen, collagen, alginate, and silk are effective in supporting cardiac cell development.
  • Pre-clinical models show enhanced post-myocardial infarction (MI) cardiac function when using these biomaterials with cells.

Conclusions:

  • Natural biomaterials are highly promising for Cardiac Tissue Engineering (CTE).
  • CTE holds significant potential for clinical solutions to cardiovascular diseases (CVD).
  • Successful CTE could substantially reduce CVD-related mortality rates.